Friday Jul 25
ROTH Capital's Debjit Chattopadhyay: Marriage of Diagnostics to New Therapies Breeds Biotech Winners
July 25, 2014 Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease.
Customer Interaction Solutions
Iradimed Corporation Announces Closing of Initial Public Offering
IRADIMED CORPORATION , the leading provider of non-magnetic intravenous infusion pump systems that are safe for use during magnetic resonance imaging procedures, announced that it has closed its initial public offering of 2,318,400 shares of common stock at a price of $6.25 per share, including 302,400 shares sold pursuant to the over-allotment ... (more)
CymaBay Therapeutics Announces Proposed Offering of Common Stock
CymaBay Therapeutics, Inc. today announced that it has commenced an underwritten public offering of 3,500,000 shares of its common stock.
Why Sequential Brands Group (SQBG) Stock Is Higher Today
Separately, TheStreet Ratings team rates SEQUENTIAL BRANDS GROUP INC as a Hold with a ratings score of C+.